The cytochrome P-450 system is the principal monooxygenase system which metabolizes foreign chemicals to both inactive compounds as well as activating them to mutagens and carcinogens. Some of these enzymes are polymorphic in both man and rodents. A polymorphism in a human P-450 (Hp1-1) immunochemically related to rat liver P- 450g has recently been reported. This P-450 appears to be present 1 about 50% of the human population and absent in the remainder. The rat appears to be a good model for the human since rat P-450g is also present in 50% of the population and absent in the remainder. In order to obtain molecular probes to further study this defect in rats and humans, a cDNA library was made from a high 450g rat. Several cDNAs were identified with specific antibody to P-450g. A full-length cDNA for P-450g has been completely sequenced. This cytochrome contains considerable homology to other cytochromes in the P-450IIc subfamily and to the cDNA for the human P-450, Hp1-1. Based on computer analysis, a specific oligonucleotide region of the P-450g cDNA was selected for use in Northerns and Southerns. This oligoprobe confirmed the P-450g in polymorphism rats. However, Northern analysis of RNA from +g and -g rats revealed no difference in mRNA content of +g and -9 phenotypes suggesting that -g rats might contain an alternate, perhaps defective mRNA. Additional studies underway include development in the fetus and neonate and studies to determine whether any extraheptic tissues (more readily studied from humans) contain this RNA. A cDNA library has been constructed from -g male rats, and several putative clones have been selected by hybridization studies. These clones are presently being sequenced to determine whether they are defective, and to develop oligonucleotide probes to allow us to differentiate between +g and -g phenotypes. We are in the process of obtaining human liver samples to investigate the possible role of the human P-450g homolog as a risk factor for liver cancer.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Intramural Research (Z01)
Project #
1Z01ES021024-08
Application #
3918608
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
8
Fiscal Year
1988
Total Cost
Indirect Cost
Name
U.S. National Inst of Environ Hlth Scis
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Makia, Ngome L; Goldstein, Joyce A (2016) CYP2C8 Is a Novel Target of Peroxisome Proliferator-Activated Receptor ? in Human Liver. Mol Pharmacol 89:154-64
Langaee, Taimour Y; Zhu, Hao-Jie; Wang, Xinwen et al. (2014) The influence of the CYP2C19*10 allele on clopidogrel activation and CYP2C19*2 genotyping. Pharmacogenet Genomics 24:381-6
Shi, Zhe; Yang, Wenjun; Goldstein, Joyce A et al. (2014) Med25 is required for estrogen receptor alpha (ER?)-mediated regulation of human CYP2C9 expression. Biochem Pharmacol 90:425-31
Makia, Ngome L; Surapureddi, Sailesh; Monostory, Katalin et al. (2014) Regulation of human CYP2C9 expression by electrophilic stress involves activator protein 1 activation and DNA looping. Mol Pharmacol 86:125-37
Chen, Yuping; Coulter, Sherry; Jetten, Anton M et al. (2009) Identification of human CYP2C8 as a retinoid-related orphan nuclear receptor target gene. J Pharmacol Exp Ther 329:192-201
Delozier, Tracy C; Kissling, Grace E; Coulter, Sherry J et al. (2007) Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues. Drug Metab Dispos 35:682-8
Lee, Su-Jun; van der Heiden, Ilse P; Goldstein, Joyce A et al. (2007) A new CYP3A5 variant, CYP3A5*11, is shown to be defective in nifedipine metabolism in a recombinant cDNA expression system. Drug Metab Dispos 35:67-71
Lee, Su-Jun; Perera, Lalith; Coulter, Sherry J et al. (2007) The discovery of new coding alleles of human CYP26A1 that are potentially defective in the metabolism of all-trans retinoic acid and their assessment in a recombinant cDNA expression system. Pharmacogenet Genomics 17:169-80
Parikh, S; Ouedraogo, J-B; Goldstein, J A et al. (2007) Amodiaquine metabolism is impaired by common polymorphisms in CYP2C8: implications for malaria treatment in Africa. Clin Pharmacol Ther 82:197-203
Vyas, Piyush M; Roychowdhury, Sanjoy; Khan, Farah D et al. (2006) Enzyme-mediated protein haptenation of dapsone and sulfamethoxazole in human keratinocytes: I. Expression and role of cytochromes P450. J Pharmacol Exp Ther 319:488-96

Showing the most recent 10 out of 37 publications